Changes in Apolipoprotein E Expression in Response to Dietary and Pharmacological Modulation of Cholesterol

2003/01/01 by Suzana S. Petanceska, Suzana Petanceska, Steven DeRosa +7 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Alzheimer's disease research and treatments #Amyloidosis #Apolipoprotein B #Apolipoprotein E #Biochemistry #Biology #Cholesterol #Cholesterol and Lipid Metabolism #Disease #Endocrinology #Gene #Genetically modified mouse #Internal medicine #Medicine #Peroxisome Proliferator-Activated Receptors #Transgene

paper · doi:10.1385/jmn:20:3:395

crossref issued 2003/01/01 · crossref published 2003/01/01 · crossref published-online 2003/01/01 · openalex publication_date 2003/01/01 · crossref created 2003/11/18 · crossref deposited 2012/12/29 · openalex created_date 2025/10/10 · crossref indexed 2026/05/16 · openalex updated_date 2026/07/28

Citations

• Serum Total Cholesterol, Apolipoprotein E FC12e4 Allele, and Alzheimer’s Disease
• Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
• Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
• A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
• Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
• Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

Cited by

• Apolipoprotein E [wikipedia]